InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,866.40
(
-0.80%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.22
(
-0.39%
)
Bitcoin
64,129.76
(
-3.43%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BlueRayn

Send PM Follow Ignore
Followers 118
Posts 6733
Boards Moderated 0
Alias Born 08/24/2013

BlueRayn

Re: SamSalters post# 296

Friday, 11/10/2017 5:15:17 PM

Friday, November 10, 2017 5:15:17 PM

Post# of 438
Galliprant has nothing to do with appetite. Entyce does. Galliprant EU approval will be big. Revs in 2018 will grow and Elanco will foot the mfg bill. Costs or not Galliprant is giving people's dogs a new lease on quality of life. Nevertheless, the stock is in overbought territory

Cheers

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up